Despite Medtronic Plc [MDT]’s great opportunity, the stock is a bit overvalued

The price of Medtronic Plc (NYSE:MDT) shares last traded on Wall Street rose 0.16% to $91.35.

MDT stock price is now 6.96% away from the 50-day moving average and 7.55% away from the 200-day moving average. The market capitalization of the company currently stands at $117.14B.

With the price target enhanced from $98 to $105, RBC Capital Mkts Upgraded its rating from Sector Perform to Outperform for Medtronic Plc (NYSE: MDT). On August 21, 2024, Oppenheimer reiterated its ‘Perform’ rating on the stock by increasing its target price from $92 to quote $94, while ‘UBS’ rates the stock as ‘Neutral’

In other news, Wall Brett A., EVP & Pres Neuroscience sold 12,437 shares of the company’s stock on Jan 24 ’25. The stock was sold for $1,119,330 at an average price of $90.00. Upon completion of the transaction, the EVP & Pres Neuroscience now directly owns 40,979 shares in the company, valued at $3.74 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 24 ’25, Officer Wall Brett A. bought 12,437 shares of the business’s stock. A total of $1,119,330 was incurred on buying the stock at an average price of $90.00. A total of 0.12% of the company’s stock is owned by insiders.

During the past 12 months, Medtronic Plc has had a low of $75.96 and a high of $93.08. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 1.84, and a quick ratio of 1.39. According to the stock market information, the enterprise value for the company is $132568342528, which is based on a 27.88 price-to-earnings ratio, a 4.24 price-to-earnings-growth ratio, and a beta of 0.83. The fifty day moving average price for MDT is $85.3004 and a two-hundred day moving average price translates $84.874 for the stock.

The latest earnings results from Medtronic Plc (NYSE: MDT) was released for 2024-07-26. The net profit margin was 13.00% and return on equity was 8.58% for MDT. The company reported revenue of $8.4 billion for the quarter, compared to $7.98 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.25 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.